These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 14506154)

  • 1. Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer.
    Tahir SA; Ren C; Timme TL; Gdor Y; Hoogeveen R; Morrisett JD; Frolov A; Ayala G; Wheeler TM; Thompson TC
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3653-9. PubMed ID: 14506154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort.
    Tahir SA; Frolov A; Hayes TG; Mims MP; Miles BJ; Lerner SP; Wheeler TM; Ayala G; Thompson TC; Kadmon D
    Clin Cancer Res; 2006 Aug; 12(16):4872-5. PubMed ID: 16914574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells.
    Li L; Yang G; Ebara S; Satoh T; Nasu Y; Timme TL; Ren C; Wang J; Tahir SA; Thompson TC
    Cancer Res; 2001 Jun; 61(11):4386-92. PubMed ID: 11389065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum keratinocyte growth factor measurement in patients with prostate cancer.
    Mehta PB; Robson CN; Neal DE; Leung HY
    J Urol; 2000 Dec; 164(6):2151-5. PubMed ID: 11061946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer.
    Tahir SA; Yang G; Goltsov AA; Watanabe M; Tabata K; Addai J; Fattah el MA; Kadmon D; Thompson TC
    Cancer Res; 2008 Feb; 68(3):731-9. PubMed ID: 18245473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multigene methylation analysis for detection and staging of prostate cancer.
    Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Clin Cancer Res; 2005 Sep; 11(18):6582-8. PubMed ID: 16166436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a serum tumor marker for preclinical trials of mouse prostate cancer models.
    Huizen IV; Wu G; Moussa M; Chin JL; Fenster A; Lacefield JC; Sakai H; Greenberg NM; Xuan JW
    Clin Cancer Res; 2005 Nov; 11(21):7911-9. PubMed ID: 16278416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy.
    Bastian PJ; Palapattu GS; Yegnasubramanian S; Lin X; Rogers CG; Mangold LA; Trock B; Eisenberger M; Partin AW; Nelson WG
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5361-7. PubMed ID: 17875764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antibody response to Propionibacterium acnes is an independent predictor of serum prostate-specific antigen levels in biopsy-negative men.
    Shannon BA; Cohen RJ; Garrett KL
    BJU Int; 2008 Feb; 101(4):429-35. PubMed ID: 17850358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a role for serum human tissue kallikrein in detection of prostate cancer?
    Ochiai A; Shukla A; Davis JW; Fritsche HA; Bhadkamkar V; Babaian RJ
    Urology; 2007 Sep; 70(3):519-22. PubMed ID: 17905108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosis.
    Nam RK; Reeves JR; Toi A; Dulude H; Trachtenberg J; Emami M; Daigneault L; Panchal C; Sugar L; Jewett MA; Narod SA
    J Urol; 2006 Apr; 175(4):1291-7. PubMed ID: 16515983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy.
    Bastian PJ; Palapattu GS; Lin X; Yegnasubramanian S; Mangold LA; Trock B; Eisenberger MA; Partin AW; Nelson WG
    Clin Cancer Res; 2005 Jun; 11(11):4037-43. PubMed ID: 15930338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of Reg IV in urogenital organs: Frequent expression of Reg IV in prostate cancer and potential utility as serum tumor marker.
    Hayashi T; Matsubara A; Ohara S; Mita K; Hasegawa Y; Usui T; Arihiro K; Norimura S; Sentani K; Oue N; Yasui W
    Oncol Rep; 2009 Jan; 21(1):95-100. PubMed ID: 19082448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of serum macrophage migration inhibitory factor in men with prostate cancer as a novel biomarker of detection and disease progression.
    Muramaki M; Miyake H; Yamada Y; Hara I
    Oncol Rep; 2006 Jan; 15(1):253-7. PubMed ID: 16328065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer.
    Tahir SA; Yang G; Ebara S; Timme TL; Satoh T; Li L; Goltsov A; Ittmann M; Morrisett JD; Thompson TC
    Cancer Res; 2001 May; 61(10):3882-5. PubMed ID: 11358800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlative evidence that prostate cancer cell-derived caveolin-1 mediates angiogenesis.
    Yang G; Addai J; Wheeler TM; Frolov A; Miles BJ; Kadmon D; Thompson TC
    Hum Pathol; 2007 Nov; 38(11):1688-95. PubMed ID: 17707459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a sensitive and specific enzyme-linked immunosorbent assay for thymosin beta15, a urinary biomarker of human prostate cancer.
    Hutchinson LM; Chang EL; Becker CM; Ushiyama N; Behonick D; Shih MC; DeWolf WC; Gaston SM; Zetter BR
    Clin Biochem; 2005 Jun; 38(6):558-71. PubMed ID: 15885237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Caveolin-1: a novel biomarker for prostate cancer].
    Huang WS; Wang RJ; Ding JL; Liu CY; Wang JH
    Zhonghua Nan Ke Xue; 2012 Jul; 18(7):635-8. PubMed ID: 22994052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland.
    Bjartell A; Johansson R; Björk T; Gadaleanu V; Lundwall A; Lilja H; Kjeldsen L; Udby L
    Prostate; 2006 May; 66(6):591-603. PubMed ID: 16388501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progression.
    Yang G; Timme TL; Frolov A; Wheeler TM; Thompson TC
    Cancer; 2005 Mar; 103(6):1186-94. PubMed ID: 15712208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.